Back to top

rsi: Archive

Zacks Equity Research

Down -9.96% in 4 Weeks, Here's Why You Should You Buy the Dip in N-able (NABL)

N-able (NABL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

NABLNegative Net Change

Zacks Equity Research

SurModics (SRDX) Loses -6.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

SurModics (SRDX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

SRDXNegative Net Change

Zacks Equity Research

After Plunging -15.7% in 4 Weeks, Here's Why the Trend Might Reverse for Clearside Biomedical (CLSD)

Clearside Biomedical (CLSD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

CLSDPositive Net Change

Zacks Equity Research

Down -48.76% in 4 Weeks, Here's Why Vacasa (VCSA) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Vacasa (VCSA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks Equity Research

Solaris Resources Inc. (SLSR) Loses -18.23% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Solaris Resources Inc. (SLSR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

SLSRNegative Net Change

Zacks Equity Research

After Plunging -48.23% in 4 Weeks, Here's Why the Trend Might Reverse for Markforged Holding Corporation (MKFG)

Markforged Holding Corporation (MKFG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Equity Research

Vital Farms (VITL) Loses -28.17% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Vital Farms (VITL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

VITLPositive Net Change

Zacks Equity Research

Syros Pharmaceuticals (SYRS) Loses -70.55% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Syros Pharmaceuticals (SYRS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Equity Research

Down -6.82% in 4 Weeks, Here's Why Delek Logistics Partners (DKL) Looks Ripe for a Turnaround

Delek Logistics Partners (DKL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

DKLPositive Net Change

Zacks Equity Research

Down -31.59% in 4 Weeks, Here's Why You Should You Buy the Dip in Boundless Bio, Inc. (BOLD)

Boundless Bio, Inc. (BOLD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

BOLDPositive Net Change

Zacks Equity Research

Down -33.63% in 4 Weeks, Here's Why Altus Power (AMPS) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Altus Power (AMPS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks Equity Research

After Plunging -8.92% in 4 Weeks, Here's Why the Trend Might Reverse for Edgewell Personal (EPC)

The heavy selling pressure might have exhausted for Edgewell Personal (EPC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

EPCNegative Net Change

Zacks Equity Research

SOPHiA GENETICS (SOPH) Loses -30.47% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for SOPHiA GENETICS (SOPH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

SOPHPositive Net Change

Zacks Equity Research

Down -15.86% in 4 Weeks, Here's Why You Should You Buy the Dip in Vital Energy (VTLE)

Vital Energy (VTLE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

VTLENegative Net Change

Zacks Equity Research

Down -24.66% in 4 Weeks, Here's Why Pros Holdings (PRO) Looks Ripe for a Turnaround

Pros Holdings (PRO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

PRONegative Net Change

Zacks Equity Research

Relmada Therapeutics (RLMD) Loses -43.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Relmada Therapeutics (RLMD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

RLMDNegative Net Change

Zacks Equity Research

Down -14.6% in 4 Weeks, Here's Why Haemonetics (HAE) Looks Ripe for a Turnaround

Haemonetics (HAE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

HAEPositive Net Change

Zacks Equity Research

Down -21.66% in 4 Weeks, Here's Why You Should You Buy the Dip in Fastly (FSLY)

The heavy selling pressure might have exhausted for Fastly (FSLY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

FSLYNegative Net Change

Zacks Equity Research

Down -10.33% in 4 Weeks, Here's Why You Should You Buy the Dip in Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SRPTPositive Net Change

Zacks Equity Research

Down -17.15% in 4 Weeks, Here's Why You Should You Buy the Dip in BlackRock TCP (TCPC)

BlackRock TCP (TCPC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

TCPCNegative Net Change

Zacks Equity Research

Pros Holdings (PRO) Loses -20.41% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Pros Holdings (PRO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PRONegative Net Change

Zacks Equity Research

Vital Energy (VTLE) Loses -15.02% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Vital Energy (VTLE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

VTLENegative Net Change

Zacks Equity Research

Pros Holdings (PRO) Loses -17.07% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Pros Holdings (PRO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PRONegative Net Change

Zacks Equity Research

After Plunging -10.52% in 4 Weeks, Here's Why the Trend Might Reverse for Skechers (SKX)

The heavy selling pressure might have exhausted for Skechers (SKX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

SKXNegative Net Change

Zacks Equity Research

Orchestra BioMed Holdings, Inc. (OBIO) Loses -25.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Orchestra BioMed Holdings, Inc. (OBIO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

OBIONegative Net Change